<- Go Home
BioGaia AB (publ)
BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula. Its Adult Health segment provides gut health tablets, bone health tablets, and oral health lozenges, as well as cultures, which are used as an ingredient in a licensee’s dairy product. The Other segment offers packaging solutions. It sells its products through distribution partners or through its own distribution channels. The company was incorporated in 1990 and is headquartered in Stockholm, Sweden.
Market Cap
SEK 12.0B
Volume
217.1K
Cash and Equivalents
SEK 446.3M
EBITDA
SEK 454.6M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
SEK 1.2B
Profit Margin
73.01%
52 Week High
SEK 136.30
52 Week Low
SEK 96.20
Dividend
3.38%
Price / Book Value
10.87
Price / Earnings
34.50
Price / Tangible Book Value
12.66
Enterprise Value
SEK 11.5B
Enterprise Value / EBITDA
24.92
Operating Income
SEK 437.9M
Return on Equity
30.78%
Return on Assets
19.77
Cash and Short Term Investments
SEK 446.3M
Debt
N/A
Equity
SEK 1.1B
Revenue
SEK 1.6B
Unlevered FCF
SEK 231.6M
Sector
Biotechnology
Category
N/A